The Food and Drug Administration has granted Fast Track designation to ATH434 for the treatment of multiple system atrophy.

Hovanesian: The first diagnosis is a good time to refer, because GA patients lose visual acuity somewhat predictably, as much ...

Retinal vascular change or degeneration already has been associated with Alzheimer and Parkinson disease, and the findings ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic atrophy (GA), a major cause of irreversible sight loss that affects ...

Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration. The US regulator turned ...

Anna Landre, a college student who lives with spinal muscular atrophy, found herself fighting another battle when her insurer informed her they were reducing the number of hours they would cover ...